( NASDAQ-NMS:ANTH )

News from anthera pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 13, 2014, 08:30 ET Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the first quarter ended March 31, 2014....


Mar 31, 2014, 16:30 ET Anthera Pharmaceuticals Announces Personnel Changes

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


Mar 12, 2014, 18:01 ET Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the fourth quarter and year ended...


Jan 30, 2014, 16:42 ET Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...


Nov 27, 2013, 17:00 ET Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


Oct 29, 2013, 16:30 ET Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results, clinical and regulatory update for the quarter ended...


Sep 25, 2013, 08:30 ET Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting

Anthera Pharmaceuticals (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


Jul 30, 2013, 17:14 ET Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2013....


Jul 12, 2013, 17:00 ET Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced today that it has filed a Certificate of Amendment to its Amended and Restated Certificate...


Jun 24, 2013, 08:30 ET Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with autoimmune...


Jun 21, 2013, 16:45 ET Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) (the "Company"), a biopharmaceutical company focused on developing and commercializing products...


Jun 12, 2013, 16:30 ET Anthera Pharmaceuticals Announces Personnel Changes

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of May Liu as its Senior Vice President, Finance and...


May 31, 2013, 15:00 ET Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


May 13, 2013, 17:23 ET Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31st,...


May 07, 2013, 16:30 ET Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...


May 03, 2013, 14:06 ET Anthera Announces First Quarter 2013 Financial Report and Conference Call

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


Apr 05, 2013, 17:45 ET Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...


Mar 27, 2013, 16:15 ET Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...


Mar 26, 2013, 16:15 ET Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter and fiscal year ended...


Mar 22, 2013, 08:00 ET Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...